Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0605579103PMID 16894141PMCID PMC1533802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.

  2006cited by this paper
• Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer.

  2006cited by this paper
• The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

  2006cited by this paper
• Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

  2006cited by this paper
• Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.

  2006cited by this paper
• Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

  2006cited by this paper
• The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

  2005cited by this paper
• Analysis of ovarian cancer cell lines using array‐based comparative genomic hybridization

  2005cited by this paper
• Novel role for PDEF in epithelial cell migration and invasion.

  2005cited by this paper
• Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.

  2005cited by this paper
• Multiple microalterations detected at high frequency in oral cancer.

  2005cited by this paper
• Functional analysis of PIK3CA gene mutations in human colorectal cancer.

  2005cited by this paper
• The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

  2005cited by this paper
• Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.

  2005cited by this paper
• Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.

  2005cited by this paper
• The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

  2005cited by this paper
• Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma

  2005cited by this paper
• Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

  2005cited by this paper
• Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma

  2005cited by this paper
• Modelling glandular epithelial cancers in three-dimensional cultures

  2005cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.

  2003cited by this paper
• Lats2, a putative tumor suppressor, inhibits G1/S transition

  2003cited by this paper
• hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.

  2003cited by this paper
• The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila

  2003cited by this paper
• Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis.

  2003cited by this paper
• The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.

  2003cited by this paper
• Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis.

  2003cited by this paper
• Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner

  2003cited by this paper
• Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling

  2002cited by this paper
• Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila

  2002cited by this paper
• Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.

  2002cited by this paper
• salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.

  2002cited by this paper
• Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.

  2001cited by this paper
• Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

  2001cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity*

  2001cited by this paper
• TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

  2001cited by this paper
• Physical interaction with Yes-associated protein enhances p73 transcriptional activity.

  2001cited by this paper
• A WW domain‐containing Yes‐associated protein (YAP) is a novel transcriptional co‐activator

  1999cited by this paper
• Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity

  1999cited by this paper
• Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction

  1999cited by this paper
• IAP family proteins--suppressors of apoptosis.

  1999cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998cited by this paper
• Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization.

  1996cited by this paper
• The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.

  1995cited by this paper
• Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.

  1995cited by this paper
• Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.

  1994cited by this paper
• A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

  1993cited by this paper
• Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

  1993cited by this paper
• Activation of the transforming potential of p60c-src by a single amino acid change.

  1986cited by this paper
• Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts.

  1984cited by this paper
• Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change

  1982cited by this paper

• The emerging role of exosomal circRNAs in modulating apoptotic pathways and overcoming cancer therapy resistance.

  2026cites this paper
• Identifying the Role of YAP in the Development of Rumen Epithelium Using 3D Organoid

  2025cites this paper
• Synergistic interplay and dual-target therapeutics: unraveling the coordinated network of SIK2 and PARP-1 in cancer development.

  2025cites this paper
• Oncotransformation in Bhas 42 Cell Transformation Assay by Typical Non-Genotoxic Carcinogens, PFOA and PFOS, and Time-Course Transcriptome Analysis

  2025cites this paper
• Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer

  2025cites this paper
• The recent advances and implications in cancer therapy for the hippo pathway.

  2025cites this paper
• Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond

  2025cites this paper
• HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver

  2025cites this paper
• Targeting TEAD in cancer

  2025cites this paper
• A YAP/TAZ–CDC6 Axis Initiates and Maintains Malignant Transformation

  2025cites this paper
• Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potential

  2025cites this paper
• Ultraviolet B Exposure Does Not Influence the Expression of YAP mRNA in Human Epidermal Keratinocytes—Preliminary Study

  2025cites this paper
• Blocking YAP1–Liprin-β2 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma

  2025cites this paper
• Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments

  2025cites this paper
• Targeting YAP/TAZ-TEAD and their protein-protein interaction for precision cancer therapy.

  2025cites this paper
• PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells.

  2025cites this paper
• Progress in Prevention and Treatment of Breast Cancer by Traditional Chinese Medicine Targeting Hippo Signaling Pathway

  2025cites this paper
• Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment

  2025cites this paper
• Epithelial-Mesenchymal Transition Activates YAP to Drive Malignant Progression and Immune Evasion

  2025cites this paper
• YAP controls cell migration and invasion through a Rho GTPase switch.

  2025cites this paper
• Implications of Drosophila neuroblast development for tumorigenesis

  2025cites this paper
• Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis.

  2025cites this paper
• The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation

  2025cites this paper
• Decoding gene expression profiles of Hippo signaling pathway components in breast cancer

  2025cites this paper
• The Hippo pathway: Organ size control and beyond.

  2024cites this paper
• Loss of SMARCA4 induces sarcomatogenesis through epithelial–mesenchymal transition in ovarian carcinosarcoma

  2024cites this paper
• YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway

  2024cites this paper
• Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects

  2024cites this paper
• Exploring STK3 in melanoma: a systematic review of signaling networks and therapeutic opportunities

  2024cites this paper
• A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion

  2024cites this paper
• ARHGAP29 Is Involved in Increased Invasiveness of Tamoxifen-resistant Breast Cancer Cells and its Expression Levels Correlate With Clinical Tumor Parameters of Breast Cancer Patients

  2024cites this paper
• Skin Development and Disease: A Molecular Perspective

  2024cites this paper
• Amphiregulin Downregulates E-cadherin Expression by Activating YAP/Egr-1/Slug Signaling in SKOV3 Human Ovarian Cancer Cells

  2024cites this paper
• UBR1 promotes anaplastic thyroid carcinoma progression via stabilizing YAP through monoubiquitylation

  2024cites this paper
• Preliminary study on the cellular and molecular mechanisms of Cms1 ribosomal small subunit homolog promoting hepatocellular carcinoma progression via activation of the homolog family member A/yes-associated protein 1 signaling pathway

  2024cites this paper
• Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP

  2024cites this paper
• Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer

  2024cites this paper
• Meme kanseri hastalarında östrojen reseptörü ile YAP ifadesi arasındaki ilişki: bir meta-analiz çalışması

  2024cites this paper
• Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.

  2024cites this paper
• Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases

  2024cites this paper
• Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer

  2024cites this paper
• Hepatocytes differentiate into intestinal epithelial cells through a hybrid epithelial/mesenchymal cell state in culture

  2024influential citation
• Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells

  2024cites this paper
• EGFR and Hippo signaling pathways are involved in organophosphate esters–induced proliferation and migration of triple-negative breast cancer cells

  2024influential citation
• A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63

  2024cites this paper
• Machine learning-based identification and validation of aging-related genes in cardiomyocytes from patients with atrial fibrillation.

  2024cites this paper
• Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma

  2024cites this paper
• Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.

  2024cites this paper
• MEF2D Functions as a Tumor Suppressor in Breast Cancer

  2024cites this paper
• CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer.

  2024cites this paper
• Research progress of the Otubains subfamily in hepatocellular carcinoma.

  2024cites this paper
• Transient proliferation by reversible YAP and mitogen-control of the cyclin D1/p27 ratio

  2024cites this paper
• A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancer

  2024cites this paper
• Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship

  2024cites this paper
• Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma

  2024cites this paper
• Circular RNA hsa_circ_0098181 inhibits metastasis in Hepatocellular Carcinoma by activating the Hippo signaling pathway via interaction with eEF2.

  2023cites this paper
• YAP/STAT3 inhibited CD8 + T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor‐associated macrophages

  2023cites this paper
• New insights into the ambivalent role of YAP/TAZ in human cancers

  2023cites this paper
• Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer.

  2023cites this paper
• YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR‒AKT axis in patient-derived xenograft cells

  2023cites this paper
• “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies

  2023cites this paper
• An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

  2023cites this paper
• The Role of TEAD2 in Malignant Tumors and Research Progress

  2023cites this paper
• The oncogenic roles and clinical implications of YAP/TAZ in breast cancer

  2023cites this paper
• The relationship between the Hippo signaling pathway and bone metastasis of breast cancer

  2023cites this paper
• TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage

  2023cites this paper
• CCDC115 inhibits autophagy‐mediated degradation of YAP to promote cell proliferation

  2023cites this paper
• Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK/p-paxillin/YAP signaling

  2023cites this paper
• The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment

  2023cites this paper
• Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation.

  2023cites this paper
• Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review.

  2023cites this paper
• Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential

  2023cites this paper
• Wnt/PCP-YAP-BIRC2 axis maintains cartilage stem/progenitor cell homeostasis in osteoarthritis

  2023cites this paper
• TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells

  2023cites this paper
• Roles of salt-inducible kinases in cancer (Review)

  2023cites this paper
• Control of stem cell renewal and fate by YAP and TAZ

  2023cites this paper
• Development of a New HiBiT Biosensor Monitoring Stability of YAP/TAZ Proteins in Cells

  2023cites this paper
• On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence

  2023cites this paper
• Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer

  2023cites this paper
• Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma

  2023cites this paper
• The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway

  2023cites this paper
• Hippo pathway in intestinal diseases: focusing on ferroptosis

  2023cites this paper
• Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously.

  2022cites this paper
• Role of the Hippo pathway in liver regeneration and repair: recent advances

  2022cites this paper
• NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling

  2022cites this paper
• Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques

  2022cites this paper
• The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance

  2022cites this paper
• The role of YAP in the control of the metastatic potential of oral cancer

  2022cites this paper
• RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis

  2022cites this paper
• Intestinal myofibroblasts regulate intestinal epithelial cell plasticity via YAP/TAZ

  2022cites this paper
• Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.

  2022cites this paper
• Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling.

  2022cites this paper
• Emerging Role of YAP and the Hippo Pathway in Prostate Cancer

  2022cites this paper
• Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism

  2022cites this paper
• Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies

  2022cites this paper
• The Hippo pathway regulates axis formation and morphogenesis in Hydra

  2022cites this paper
• LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells

  2022cites this paper
• The biology of YAP in programmed cell death

  2022cites this paper
• Decoding YAP dependent transcription in the liver

  2022cites this paper